Literature DB >> 26085727

Synchronous Occurance of Acute Myeloid Leukemia and Rhabdomyosarcoma.

A V Jayasudha1, Rekha A Nair1, S Renu1, R Binitha2, K S Reghu2, P Kusumakumary2.   

Abstract

Metachronous primary distinct tumors are frequently and increasingly encountered in oncology clinical practice of recent times, but synchronous tumours are still a rarity. We report an unusual case of a 2 year old male child who had synchronous occurrence of rhabdomyosarcoma of pelvis and acute myeloid leukemia.Our search of literature suggests that this may be the first reported case of simultaneous occurrence of these two malignancies.

Entities:  

Keywords:  Acute myeloid leukemia; Rhabdomyosarcoma; Synchronous tumors

Year:  2014        PMID： 26085727      PMCID： PMC4465506          DOI： 10.1007/s12288-014-0474-1

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


  8 in total

1.  Pathway simulations in common oncogenic drivers of leukemic and rhabdomyosarcoma cells: a systems biology approach.

Authors:  George I Lambrou; Apostolos Zaravinos; Maria Adamaki; Demetrios A Spandidos; Fotini Tzortzatou-Stathopoulou; Spiros Vlachopoulos
Journal:  Int J Oncol       Date:  2012-02-07       Impact factor: 5.650

2.  Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report.

Authors:  N Anensen; J Skavland; C Stapnes; A Ryningen; A-L Børresen-Dale; B T Gjertsen; Ø Bruserud
Journal:  Leukemia       Date:  2006-04       Impact factor: 11.528

3.  Cancer in Noonan, Costello, cardiofaciocutaneous and LEOPARD syndromes.

Authors:  Christian P Kratz; Suthee Rapisuwon; Helen Reed; Henrik Hasle; Philip S Rosenberg
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-04-15       Impact factor: 3.908

Review 4.  Hematologic masquerade of rhabdomyosarcoma.

Authors:  A A Sandberg; J F Stone; L Czarnecki; J D Cohen
Journal:  Am J Hematol       Date:  2001-09       Impact factor: 10.047

5.  Synchronous and metachronous malignant tumours expect the unexpected.

Authors:  Itrat Mehdi; Arshad Hussain Shah; Mohammad Shafi Moona; Kamal Verma; Abougella Abussa; Ramah Elramih; Hussein El-Hashmi
Journal:  J Pak Med Assoc       Date:  2010-11       Impact factor: 0.781

6.  Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on Intergroup Rhabdomyosarcoma Study III: an interim report.

Authors:  R Heyn; F Khan; L G Ensign; S S Donaldson; F Ruymann; M A Smith; T Vietti; H M Maurer
Journal:  Med Pediatr Oncol       Date:  1994

7.  Sequential development of Wilms tumor, T-cell acute lymphoblastic leukemia, medulloblastoma and myeloid leukemia in a child with type 1 neurofibromatosis: a clinical and cytogenetic case report.

Authors:  G Perilongo; C A Felix; A T Meadows; P Nowell; J Biegel; B J Lange
Journal:  Leukemia       Date:  1993-06       Impact factor: 11.528

Review 8.  Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.

Authors:  Anna T Meadows; Debra L Friedman; Joseph P Neglia; Ann C Mertens; Sarah S Donaldson; Marilyn Stovall; Sue Hammond; Yutaka Yasui; Peter D Inskip
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.